# A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects

> **NCT00397566** · PHASE2 · WITHDRAWN · sponsor: **Bristol-Myers Squibb**

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** HIV Integrase Inhibitor (BMS-707035)

## Key facts

- **NCT ID:** NCT00397566
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-02
- **Primary completion:** —
- **Final completion:** 2007-02
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00397566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00397566, "A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00397566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*